Chan Mitchell

CIK 00017893353 companiesROCKVILLE, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001789335

Recent Transactions

20 trades

Award
REGENXBIO Inc.$RGNX
Common Stock
2026-01-06+73,749→ 127,717 total
Award
REGENXBIO Inc.$RGNX
Stock Options (Right to buy)
2026-01-06+39,650→ 39,650 total
Tax Payment
REGENXBIO Inc.$RGNX
Common Stock
2025-09-01$8.93/sh−4,901→ 53,968 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2025-06-17+20,100→ 20,100 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Common Stock
2025-03-28+3,167→ 3,167 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Restricted Stock Units
2025-03-28−3,167→ 6,333 total
Award
REGENXBIO Inc.$RGNX
Stock Options (Right to buy)
2025-01-02+62,547→ 62,547 total
Award
REGENXBIO Inc.$RGNX
Stock Options (Right to buy)
2024-09-16+289,362→ 289,362 total
Award
REGENXBIO Inc.$RGNX
Common Stock
2024-09-16+58,869→ 58,869 total
Award
Avalo Therapeutics, Inc.$AVTX
Restricted Stock Units
2024-08-13+9,500→ 9,500 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2024-08-13+24,600→ 24,600 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2023-12-20+3,334→ 3,334 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2022-06-14+40,000→ 40,000 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2021-12-01+80,000→ 80,000 total
Disposition to Issuer
Viela Bio, Inc.
Stock Option (right to buy)
2021-03-15−13,000→ 0 total
Disposition to Issuer
Viela Bio, Inc.
Stock Option (right to buy)
2021-03-15−30,000→ 0 total
Disposition to Issuer
Viela Bio, Inc.
Stock Option (right to buy)
2021-03-15−67,500→ 0 total
Disposition to Issuer
Viela Bio, Inc.
Stock Option (right to buy)
2021-03-15−50,056→ 0 total
Disposition to Issuer
Viela Bio, Inc.
Common Stock
2021-03-13$53.00/sh−37,500→ 0 total
Award
Viela Bio, Inc.
Stock Option (Right to Buy)
2020-03-02+50,056→ 50,056 total

Companies

Recent Filings

Address

C/O REGENXBIO INC. 9804 MEDICAL CENTER DRIVE

ROCKVILLE, MD, 20850

View on SEC.gov